Position in CAI
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,564
-$12 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#220
of 246 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CAI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ascentis Wealth Management, LLC holds $110,780 across 9 Biotechnology names. CAI ranks #8 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
68 | $33,770 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
400 | $31,716 | |
| 3 | ASND |
Ascendis Pharma A/S
|
56 | $14,935 | |
| 4 | ABVX |
Abivax S.A.
|
107 | $14,257 | |
| 5 | DBVT |
DBV Technologies S.A.
|
259 | $4,246 | |
| 6 | GMAB |
Genmab A/S
|
137 | $3,763 | |
| 7 | ARGX |
Argenx SE
|
4 | $3,711 | |
| 8 | CAI |
Caris Life Sciences, Inc.
This page
|
200 | $3,564 |
All Filings in CAI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,564 | 200 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $3,576 | 200 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $5,396 | 200 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $6,050 | 200 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $5,344 | 200 | Shares | Sole | 2025-07-16 | |
| No filing history on record for this holder in this stock. | ||||||